Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India

After securing a clearance by its parent company in the United Kingdom and Bahrain, Pfizer India has become the first pharmaceutical firm to seek from the Drugs Controller General of India (DCGI) an emergency use authorisation for its COVID-19 vaccine in India. The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the country, besides waiver of clinical trials on Indian population in accordance with the special provisions under the New Drugs and Clinical Trials Rules, 2019, official sources said.

from IndiaTV India: Google News Feed https://ift.tt/3grMXEB
via Today’s News Headlines